DRKS00021762
Completed
Not Applicable
Evaluation of the quality of life of patients after anatomical lung resection in NSCLC taking psychosocial factors into consideration - PSYCA
Charité Berlin0 sites168 target enrollmentJune 12, 2020
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C34
- Sponsor
- Charité Berlin
- Enrollment
- 168
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •diagnosed non\-small lung cancer carcinoma (NSCLC)
- •anatomic pulmonary resection
- •informed consent given
- •age \> 18 years
- •Karnofsky Performance Index Scale \> 80%
- •ECOG score \> 1
- •no prior onocologial findings (past 20 years)
Exclusion Criteria
- •cognitive skills are not sufficient for participation
- •German proficiency skills are not sufficient
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment of Quality of Life in patients undergoing surgery for cancer of PenisCTRI/2020/10/028180Dr Suyog Shetty35
Recruiting
Not Applicable
Evaluation of quality of life of patients with food allergy and their guardians using a questionnairefood allergyJPRN-UMIN000044751ational Hospital Organization Sagamihara National Hospital200
Not yet recruiting
Not Applicable
Prospective quality of life analysis of patients with metastatic breast cancer during and after radiotherapyC79.9Secondary malignant neoplasm, unspecified siteDRKS00025331niversitätsklinikum Freiburg Klinik für Strahlenheilkunde100
Completed
Phase 2
Hypofractionated radiotherapy for the palliation of patients with advanced head and neck cancer who are unsuitable for an attempt at curative treatmentACTRN12605000114640Dr Sandro Porceddu40
Not yet recruiting
Not Applicable
A study on quality of life in Prosthakola veekkam (Benign prostatic hyperplasia) patients taking siddha treatmentHealth Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptomsCTRI/2023/02/049626ational Institute of Siddha